- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
迄今为止，共20家主力机构，持仓量总计3557.38万股，占流通A股39.05%
- 波段诊断：
-
技术面诊股
诊断结果：7.0技术面打败了61%的股票
技术面评分前10的股票
近期的平均成本为71.58元，股价在成本上方运行。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为71.58元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"71.58","date":1593677795,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2020.07.03","stock":"-0.01","trade":"1.21","ind":"1.33"},{"date":"2020.07.02","stock":"-4.28","trade":"-0.66","ind":"1.29"},{"date":"2020.07.01","stock":"-2.55","trade":"-1.30","ind":"1.01"},{"date":"2020.06.30","stock":"0.58","trade":"1.93","ind":"2.04"},{"date":"2020.06.29","stock":"7.19","trade":"2.69","ind":"-0.52"},{"date":"2020.06.24","stock":"0.27","trade":"0.17","ind":"0.17"},{"date":"2020.06.23","stock":"6.27","trade":"1.93","ind":"0.78"},{"date":"2020.06.22","stock":"0.06","trade":"0.80","ind":"0.29"},{"date":"2020.06.19","stock":"4.23","trade":"1.25","ind":"1.51"},{"date":"2020.06.18","stock":"-4.70","trade":"-3.24","ind":"0.65"},{"date":"2020.06.17","stock":"1.25","trade":"1.78","ind":"0.19"},{"date":"2020.06.16","stock":"5.43","trade":"2.28","ind":"1.85"},{"date":"2020.06.15","stock":"0.30","trade":"3.50","ind":"-0.53"},{"date":"2020.06.12","stock":"6.09","trade":"3.16","ind":"0.07"},{"date":"2020.06.11","stock":"-0.99","trade":"-0.32","ind":"-0.81"},{"date":"2020.06.10","stock":"1.41","trade":"1.87","ind":"0.46"},{"date":"2020.06.09","stock":"4.81","trade":"1.20","ind":"0.61"},{"date":"2020.06.08","stock":"-5.31","trade":"-0.72","ind":"0.31"},{"date":"2020.06.05","stock":"1.38","trade":"0.17","ind":"0.37"},{"date":"2020.06.04","stock":"3.58","trade":"0.85","ind":"0.28"},{"date":"2020.06.03","stock":"0.08","trade":"1.55","ind":"-0.04"}]
艾德生物,深证成指,医疗器械服务指数
压力支撑
该股压力位为71.18元，支撑位为69.41元。
[{"text":"\u538b\u529b\u4f4d","value":"71.18","date":1593705600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"69.41","date":1593705600,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.3资金面打败了73%的股票
主力控盘前10的股票
行业资金
医疗器械服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月03日 20:30
| 机构今日流向(万元) | 1475.72 | 机构5日流向(万元) | -2738.62 |
| 机构10日流向(万元) | -6324.69 | 机构20日流向(万元) | -2740.23 |
机构持仓
2020-03-31 与 2019-12-31 相比，主力机构持仓量减少1488.97万股，其中基金净减仓1家，主力净减仓114家，请投资者中长期谨慎为宜。
截止2020-03-31，共20家主力机构（基金11家，一般法人7家，社保基金2家），持仓量总计3557.38万股，占流通A股39.05%
其中，基金持仓与2019-12-31相比：
增仓：2家 ，增持 10.58万股
减仓：3家 ，减持 5.04万股
新出现在主力名单中：4家 ，持有374.59万股
从主力名单中消失：118家 ，原持有1674.84万股
其中，基金持仓与2019-12-31相比：
增仓：2家 ，增持 10.58万股
减仓：3家 ，减持 5.04万股
新出现在主力名单中：4家 ，持有374.59万股
从主力名单中消失：118家 ，原持有1674.84万股
消息面诊股
诊断结果：5.5消息面打败了48%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 艾德生物限售解禁特别提示(2020-07-03)
2020-07-03 - 艾德生物14:30大单揭秘:主动大单卖出9105手
2020-07-02 - 艾德生物14:30大单揭秘:主动大单卖出9894手
2020-07-01 - 西南证券--医药行业政策点评：新版化药&生物制品注
2020-07-01 - 艾德生物10:30大单揭秘:主动大单卖出2506手
2020-07-01 - 艾德生物限售解禁特别提示(2020-07-01)
2020-07-01 - 上市公司专利发明谁最强？生物医药企业更重科研
2020-06-30 - 厦门致力创建“生命科技之城”
2020-06-29 - 艾德生物10:30大单揭秘:主动大单买入2542手
2020-06-29 - 艾德生物：持续关注肿瘤早筛领域的研究进展
2020-06-24
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2020-04-14 |
| 利好 | 分红转增 | 10转5股派2.5元(含税) | 2020-04-14 |
| 一般消息 | 募资投向 | 2020-04-14 | |
| 利空 | 业绩预告 | 业绩预降 | 2020-04-09 |
| 利好 | 业绩预告 | 业绩预增 | 2020-01-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2019-07-30 |
| 一般消息 | 重大事项 | 关联交易 | 2019-07-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：3.2行业面打败了24%的股票
医疗器械服务行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2020.07.03","price":"1.33","value":"1.21"},{"date":"2020.07.02","price":"1.29","value":"-0.66"},{"date":"2020.07.01","price":"1.01","value":"-1.30"},{"date":"2020.06.30","price":"2.04","value":"1.93"},{"date":"2020.06.29","price":"-0.52","value":"2.69"},{"date":"2020.06.24","price":"0.17","value":"0.17"},{"date":"2020.06.23","price":"0.78","value":"1.93"},{"date":"2020.06.22","price":"0.29","value":"0.80"},{"date":"2020.06.19","price":"1.51","value":"1.25"},{"date":"2020.06.18","price":"0.65","value":"-3.24"},{"date":"2020.06.17","price":"0.19","value":"1.78"},{"date":"2020.06.16","price":"1.85","value":"2.28"},{"date":"2020.06.15","price":"-0.53","value":"3.50"},{"date":"2020.06.12","price":"0.07","value":"3.16"},{"date":"2020.06.11","price":"-0.81","value":"-0.32"},{"date":"2020.06.10","price":"0.46","value":"1.87"},{"date":"2020.06.09","price":"0.61","value":"1.20"},{"date":"2020.06.08","price":"0.31","value":"-0.72"},{"date":"2020.06.05","price":"0.37","value":"0.17"},{"date":"2020.06.04","price":"0.28","value":"0.85"},{"date":"2020.06.03","price":"-0.04","value":"1.55"}]
深证成指,医疗器械服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 佰仁医疗 | 72.39% | 12.06% | 5.3分 |
| 2 | 宝莱特 | 69.63% | 9.66% | 5.3分 |
| 3 | 南卫股份 | 68.40% | 13.59% | 5.7分 |
| 4 | 正川股份 | 62.03% | 24.53% | 6.2分 |
| 5 | 硕世生物 | 61.14% | 24.78% | 6.5分 |
| 6 | 万泰生物 | 56.00% | 3.77% | 4.8分 |
| 8 | 英科医疗 | 52.76% | 14.14% | 6.8分 |
| 10 | 三诺生物 | 46.14% | -0.97% | 5.4分 |
| 12 | 量子生物 | 44.50% | -0.15% | 5.4分 |
| 14 | 戴维医疗 | 40.75% | 17.02% | 6.5分 |
| 16 | 华大基因 | 37.80% | 12.63% | 6.6分 |
| 18 | 凯普生物 | 36.36% | 2.58% | 6.2分 |
| 20 | *ST华塑 | 34.51% | -9.52% | 4.4分 |
| 22 | 正海生物 | 31.97% | 6.88% | 6.1分 |
| 24 | 艾德生物 | 26.57% | 0.55% | 5.8分 |
| 26 | 利德曼 | 24.63% | -1.91% | 5.3分 |
| 28 | 蓝帆医疗 | 23.81% | 6.85% | 5.4分 |
| 30 | 理邦仪器 | 23.27% | 7.35% | 5.6分 |
| 32 | 奥美医疗 | 22.01% | 17.03% | 6.8分 |
| 34 | 阳普医疗 | 21.40% | 14.29% | 6.5分 |
| 36 | 美康生物 | 20.74% | 5.66% | 5.5分 |
| 38 | 迪瑞医疗 | 20.48% | 1.24% | 5.6分 |
| 40 | 博晖创新 | 20.12% | -0.81% | 5.1分 |
| 42 | 药明康德 | 19.46% | -0.01% | 6.6分 |
| 44 | 乐普医疗 | 17.53% | 13.36% | 6.6分 |
| 46 | 泰格医药 | 17.33% | -1.09% | 6.5分 |
| 48 | 福瑞股份 | 16.95% | 9.01% | 6.3分 |
| 50 | 海尔生物 | 15.31% | -3.71% | 4.5分 |
| 52 | 和佳医疗 | 15.09% | 1.28% | 5.2分 |
| 54 | 南微医学 | 14.12% | -3.41% | 5.3分 |
| 56 | 国新健康 | 13.24% | 9.47% | 4.7分 |
| 58 | 金域医学 | 12.47% | -4.41% | 5.0分 |
| 60 | 通策医疗 | 12.18% | 1.98% | 6.0分 |
| 62 | 热景生物 | 11.92% | 2.00% | 4.2分 |
| 64 | 昭衍新药 | 11.63% | 4.06% | 6.1分 |
| 66 | 爱尔眼科 | 10.47% | -1.82% | 5.0分 |
| 68 | 三友医疗 | 10.39% | -4.48% | 4.6分 |
| 70 | 健帆生物 | 8.85% | 1.95% | 5.8分 |
| 72 | 透景生命 | 7.68% | -1.03% | 4.2分 |
| 74 | 迈瑞医疗 | 7.28% | -0.84% | 6.1分 |
| 76 | 润达医疗 | 6.13% | 5.15% | 5.8分 |
| 78 | 冠昊生物 | 5.75% | -0.85% | 5.2分 |
| 80 | 新华医疗 | 4.66% | 4.87% | 5.6分 |
| 82 | 维力医疗 | 4.46% | 1.63% | 5.2分 |
| 84 | 贝瑞基因 | 2.97% | -6.23% | 4.3分 |
| 86 | 乐凯胶片 | 1.97% | 3.23% | 4.8分 |
| 88 | 美迪西 | 0.38% | -1.91% | 4.2分 |
| 90 | 澳洋健康 | -4.53% | -0.39% | 4.7分 |
| 92 | 览海医疗 | -6.16% | 2.55% | 4.9分 |
| 94 | 成都先导 | -6.55% | -6.41% | 3.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2020-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 26/251 ， 5/251。
[{"date":"2020-03-31","value":"2.81","vol":"1.57"},{"date":"2019-12-31","value":"16.33","vol":"6.49"},{"date":"2019-09-30","value":"13.45","vol":"9.24"},{"date":"2019-06-30","value":"9.93","vol":"4.85"},{"date":"2019-03-31","value":"4.22","vol":"1.99"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.81 | 16.33 | 13.45 | 9.93 | 4.22 |
| 行业(%) | 1.57 | 6.49 | 9.24 | 4.85 | 1.99 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"87.19","vol":"41.72"},{"date":"2019-12-31","value":"90.37","vol":"48.34"},{"date":"2019-09-30","value":"90.32","vol":"44.87"},{"date":"2019-06-30","value":"90.58","vol":"44.35"},{"date":"2019-03-31","value":"91.08","vol":"43.81"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
87.19 | 90.37 | 90.32 | 90.58 | 91.08 |
| 行业(%) | 41.72 | 48.34 | 44.87 | 44.35 | 43.81 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 67/251 ， 50/251。
[{"date":"2020-03-31","value":"-23.96","vol":"2.76"},{"date":"2019-12-31","value":"31.73","vol":"15.07"},{"date":"2019-09-30","value":"32.84","vol":"14.26"},{"date":"2019-06-30","value":"31.32","vol":"13.59"},{"date":"2019-03-31","value":"34.11","vol":"15.10"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-23.96 | 31.73 | 32.84 | 31.32 | 34.11 |
| 行业(%) | 2.76 | 15.07 | 14.26 | 13.59 | 15.10 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"-20.48","vol":"-21.74"},{"date":"2019-12-31","value":"6.89","vol":"-110.07"},{"date":"2019-09-30","value":"13.54","vol":"9.96"},{"date":"2019-06-30","value":"12.34","vol":"1.42"},{"date":"2019-03-31","value":"30.46","vol":"28.61"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-20.48 | 6.89 | 13.54 | 12.34 | 30.46 |
| 行业(%) | -21.74 | -110.07 | 9.96 | 1.42 | 28.61 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 55/251 ， 58/251。
[{"date":"2020-03-31","value":"0.08","vol":"0.10"},{"date":"2019-12-31","value":"0.62","vol":"0.52"},{"date":"2019-09-30","value":"0.45","vol":"0.39"},{"date":"2019-06-30","value":"0.30","vol":"0.26"},{"date":"2019-03-31","value":"0.14","vol":"0.11"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.08 | 0.62 | 0.45 | 0.30 | 0.14 |
| 行业(次) | 0.10 | 0.52 | 0.39 | 0.26 | 0.11 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.52","vol":"14.03"},{"date":"2019-12-31","value":"3.57","vol":"55.23"},{"date":"2019-09-30","value":"2.47","vol":"45.56"},{"date":"2019-06-30","value":"1.59","vol":"28.05"},{"date":"2019-03-31","value":"0.68","vol":"14.62"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.52 | 3.57 | 2.47 | 1.59 | 0.68 |
| 行业(次) | 14.03 | 55.23 | 45.56 | 28.05 | 14.62 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-03-31","value":"52.78","vol":"-13.37"},{"date":"2019-12-31","value":"10.38","vol":"25.83"},{"date":"2019-09-30","value":"35.94","vol":"12.01"},{"date":"2019-06-30","value":"35.41","vol":"12.20"},{"date":"2019-03-31","value":"24.90","vol":"-11.83"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 52.78 | 10.38 | 35.94 | 35.41 | 24.90 |
| 行业 | -13.37 | 25.83 | 12.01 | 12.20 | -11.83 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"","vol":"0.02"},{"date":"2019-12-31","value":"0.91","vol":"2.95"},{"date":"2019-09-30","value":"","vol":"0.03"},{"date":"2019-06-30","value":"0.73","vol":"2.88"},{"date":"2019-03-31","value":"","vol":"0.24"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.91 | - | 0.73 | - |
| 行业 | 0.02 | 2.95 | 0.03 | 2.88 | 0.24 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 76/251 ， 78/251。
[{"date":"2020-03-31","value":"5.10","vol":"4.22"},{"date":"2019-12-31","value":"5.67","vol":"4.25"},{"date":"2019-09-30","value":"5.44","vol":"4.00"},{"date":"2019-06-30","value":"5.52","vol":"3.58"},{"date":"2019-03-31","value":"13.78","vol":"3.19"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
5.10 | 5.67 | 5.44 | 5.52 | 13.78 |
| 行业 | 4.22 | 4.25 | 4.00 | 3.58 | 3.19 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"4.86","vol":"3.45"},{"date":"2019-12-31","value":"5.43","vol":"3.56"},{"date":"2019-09-30","value":"3.47","vol":"2.86"},{"date":"2019-06-30","value":"3.67","vol":"2.56"},{"date":"2019-03-31","value":"10.31","vol":"2.15"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.86 | 5.43 | 3.47 | 3.67 | 10.31 |
| 行业 | 3.45 | 3.56 | 2.86 | 2.56 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 72/251 ， 75/251。
[{"date":"2020-03-31","value":"15.61","vol":"31.58"},{"date":"2019-12-31","value":"13.82","vol":"31.15"},{"date":"2019-09-30","value":"14.32","vol":"29.94"},{"date":"2019-06-30","value":"13.92","vol":"30.61"},{"date":"2019-03-31","value":"5.71","vol":"26.98"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
15.61 | 13.82 | 14.32 | 13.92 | 5.71 |
| 行业(%) | 31.58 | 31.15 | 29.94 | 30.61 | 26.98 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.18","vol":"0.90"},{"date":"2019-12-31","value":"0.16","vol":"0.84"},{"date":"2019-09-30","value":"0.17","vol":"0.63"},{"date":"2019-06-30","value":"0.16","vol":"1.55"},{"date":"2019-03-31","value":"0.06","vol":"0.79"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.16 | 0.17 | 0.16 | 0.06 |
| 行业(%) | 0.90 | 0.84 | 0.63 | 1.55 | 0.79 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东方证券 | 2020-05-07 | 增持 | |
| 国金证券 | 2020-04-21 | 增持 | 增持 |
| 中信证券 | 2020-04-21 | 增持 | 增持 |
| 天风证券 | 2020-04-21 | 买入 | 买入 |
| 兴业证券 | 2020-04-21 | 增持 | 增持 |
| 广发证券 | 2020-04-20 | 增持 |
机构预测
机构预测该股2020年每股收益与前一年相同，长期投资价值一般。
[{"date":"2016","yellowRectValue":"0.67","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"0.94","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"1.27","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.35","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"1.90","blueLineValue":"0.86","type":"YC"}]